Urology Times
Spotlight
ASCO Annual Meeting ASCO Meeting PreviewsAUA MeetingAUA Meeting: Prostate CancerAUA Meeting PreviewsASCO GU Recaps Innovation Celebration: VideosInnovation Celebration: ArticlesUrology Times JournalUroViewVirtual Tumor BoardRisk Factors of Cardiovascular Disease and Management of Prostate Cancer
Clinical
View MoreProstate CancerBladder CancerKidney CancerBPHNext-Generation ImagingGenomic TestingKidney StonesOAB and IncontinenceSexual DysfunctionHormone Therapy
Business
View MoreHealth Law & PolicyMalpractice ConsultPractice Management
News
Clinical
All ClinicalBenign ConditionsBladder CancerBPHFemale UrologyGenitourinary CancersHormone TherapyKidney CancerKidney StonesMen's HealthNext-Generation ImagingPediatricsProstate CancerSexual DysfunctionUrologic Surgery
Media
Podcasts'Y'tubeUroViewUTv VideosAround the PracticeBPH VideosCase-Based Peer PerspectivesMedical World NewsRapid ReadoutsUrology Medical PerspectivesViewpointsVirtual Tumor Board
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Editorial Advisory BoardSupplements and Featured PublicationsUrologists in Cancer CareUrology Times Journal
Events
Live EventsVirtual Events
CME/CE
Resources
Interactive ToolsJob BoardPartnersSponsored
Subscribe
eNewsletterPrint Subscription

  • About Us
  • Advertise
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
  • MJHLS Brand Logo

© 2022 MJH Life Sciences and Urology Times. All rights reserved.

Spotlight
  • ASCO Annual Meeting
  • ASCO Meeting Previews
  • AUA Meeting
  • AUA Meeting: Prostate Cancer
  • AUA Meeting Previews
  • ASCO GU Recaps
  • Innovation Celebration: Videos
  • Innovation Celebration: Articles
  • Urology Times Journal
  • UroView
  • Virtual Tumor Board
  • Risk Factors of Cardiovascular Disease and Management of Prostate Cancer
ClinicalSee All >
  • Prostate Cancer
  • Bladder Cancer
  • Kidney Cancer
  • BPH
  • Next-Generation Imaging
  • Genomic Testing
  • Kidney Stones
  • OAB and Incontinence
  • Sexual Dysfunction
  • Hormone Therapy
BusinessSee All >
  • Health Law & Policy
  • Malpractice Consult
  • Practice Management
  • About Us
  • Advertise
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.

Second-Line Treatment Options in Advanced Prostate Cancer

Robert Dreicer, MD, provides an overview of advances in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and available and emerging second-line treatment options for mCRPC.

EP1: First-Line Therapy Options in Metastatic Castration-Resistant Prostate Cancer

January 21st 2022

Robert Dreicer, MD, provides an overview of the first-line therapy options available in metastatic castration-resistant prostate cancer and the recent advances in detection, diagnosis, and treatment.

EP2: Second-Line Therapy Options in Metastatic Castration-Resistant Prostate Cancer

January 21st 2022

Robert Dreicer, MD, discusses the available second-line therapy options and unmet needs in metastatic castration-resistant prostate cancer.

EP3: Sabizabulin for Metastatic Castration-Resistant Prostate Cancer

January 28th 2022

A prostate cancer expert explains the potential advantages of sabizabulin, a new treatment for metastatic castration-resistant prostate cancer currently in a phase III clinical trial.

EP4: Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer

January 28th 2022

Robert Dreicer, MD, describes the future of metastatic castration-resistant prostate cancer.